title: Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.
abstract: Unrelated bone marrow transplantation (BMT) is often complicated by fatal opportunistic infections. To evaluate features unique to immune reconstitution after unrelated BMT, the lymphoid phenotype, in vitro function, and life-threatening opportunistic infections after unrelated and related T-cell-depleted (TCD) BMT were analyzed longitudinally and compared. The effects of posttransplant donor leukocyte infusions to treat or prevent cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infections on immune reconstitution were also analyzed. This study demonstrates that adult recipients of TCD unrelated BMTs experience prolonged and profound deficiencies of CD3(+), CD4(+), and CD8(+) T-cell populations when compared with pediatric recipients of unrelated BMT and adults after related BMT (P <.01), that these adults have a significantly increased risk of life-threatening opportunistic infections, and that the rate of recovery of CD4 T cells correlates with the risk of developing these infections. Recovery of normal numbers of CD3(+), CD8(+), and CD4(+) T-cell populations is similar in children after related or unrelated BMT. This study also demonstrates that adoptive immunotherapy with small numbers of unirradiated donor leukocytes can be associated with rapid restoration of CD3(+), CD4(+), and CD8(+) T-cell numbers, antigen-specific T-cell responses, and resolution of CMV- and EBV-associated disease after unrelated TCD BMT.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. smallt@mskcc.org
authors.forename: T N
authors.initials: TN
authors.lastname: Small
authors.forename: E B
authors.initials: EB
authors.lastname: Papadopoulos
authors.forename: F
authors.initials: F
authors.lastname: Boulad
authors.forename: P
authors.initials: P
authors.lastname: Black
authors.forename: H
authors.initials: H
authors.lastname: Castro-Malaspina
authors.forename: B H
authors.initials: BH
authors.lastname: Childs
authors.forename: N
authors.initials: N
authors.lastname: Collins
authors.forename: A
authors.initials: A
authors.lastname: Gillio
authors.forename: D
authors.initials: D
authors.lastname: George
authors.forename: A
authors.initials: A
authors.lastname: Jakubowski
authors.forename: G
authors.initials: G
authors.lastname: Heller
authors.forename: M
authors.initials: M
authors.lastname: Fazzari
authors.forename: N
authors.initials: N
authors.lastname: Kernan
authors.forename: S
authors.initials: S
authors.lastname: MacKinnon
authors.forename: P
authors.initials: P
authors.lastname: Szabolcs
authors.forename: J W
authors.initials: JW
authors.lastname: Young
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Reilly
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control; D020031:Epstein-Barr Virus Infections / Q000276:immunology / Q000517:prevention & control; D005260:Female; D006801:Humans; D016219:Immunotherapy, Adoptive; D017708:Leukocyte Transfusion; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000276:immunology* / Q000517:prevention & control; D013601:T-Lymphocytes / Q000276:immunology*